Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Chun Hahn, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by William Hahn and John Asara.
Connection Strength

0.559
  1. Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer. Elife. 2017 10 31; 6.
    View in: PubMed
    Score: 0.183
  2. PIK3CA mutant tumors depend on oxoglutarate dehydrogenase. Proc Natl Acad Sci U S A. 2017 04 25; 114(17):E3434-E3443.
    View in: PubMed
    Score: 0.176
  3. KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer. Elife. 2017 02 01; 6.
    View in: PubMed
    Score: 0.174
  4. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell. 2009 May 14; 34(4):461-72.
    View in: PubMed
    Score: 0.025
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.